Financhill
Sell
38

NVR Quote, Financials, Valuation and Earnings

Last price:
$8,272.63
Seasonality move :
30.26%
Day range:
$8,105.00 - $8,323.25
52-week range:
$6,800.00 - $9,964.77
Dividend yield:
0%
P/E ratio:
16.92x
P/S ratio:
2.73x
P/B ratio:
5.94x
Volume:
60.8K
Avg. volume:
24.1K
1-year change:
20.88%
Market cap:
$25.4B
Revenue:
$9.5B
EPS (TTM):
$489.16
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $7.4B $7.5B $9B $10.5B $9.5B
Revenue Growth (YoY) 3.14% 1.96% 18.74% 17.62% -9.52%
 
Cost of Revenues $5.8B $5.9B $6.8B $7.7B $7.1B
Gross Profit $1.6B $1.6B $2.2B $2.9B $2.5B
Gross Profit Margin 20.96% 21.32% 24.52% 27.29% 26.05%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $527.4M $509.7M $563.4M $625.3M $680M
Other Inc / (Exp) $2.9M $3.2M $3.8M $5M $4.4M
Operating Expenses $502.6M $492.8M $556.9M $588.3M $532M
Operating Income $1B $1.1B $1.6B $2.3B $2B
 
Net Interest Expenses $25.4M $40.9M $53.1M $39.5M $27.7M
EBT. Incl. Unusual Items $1B $1.1B $1.6B $2.3B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $147.3M $176.8M $353.7M $527.6M $336.8M
Net Income to Company $878.5M $901.2M $1.2B $1.7B $1.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $878.5M $901.2M $1.2B $1.7B $1.6B
 
Basic EPS (Cont. Ops) $241.31 $244.11 $345.37 $525.20 $491.52
Diluted EPS (Cont. Ops) $221.13 $230.11 $320.48 $491.82 $463.31
Weighted Average Basic Share $3.6M $3.7M $3.6M $3.3M $3.2M
Weighted Average Diluted Share $4M $3.9M $3.9M $3.5M $3.4M
 
EBITDA $1.1B $1.1B $1.7B $2.3B $2B
EBIT $1.1B $1.1B $1.6B $2.3B $2B
 
Revenue (Reported) $7.4B $7.5B $9B $10.5B $9.5B
Operating Income (Reported) $1B $1.1B $1.6B $2.3B $2B
Operating Income (Adjusted) $1.1B $1.1B $1.6B $2.3B $2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2B $2.4B $2.8B $2.6B $2.7B
Revenue Growth (YoY) 4.06% 20.37% 15.95% -7.42% 6.36%
 
Cost of Revenues $1.5B $1.8B $2.1B $1.9B $2.1B
Gross Profit $456.2M $580M $687.9M $671.9M $686.6M
Gross Profit Margin 22.9% 24.19% 24.74% 26.1% 25.08%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $125.9M $135.2M $153.7M $166.8M $176.1M
Other Inc / (Exp) $887K $1M $1.3M $1.2M $1.4M
Operating Expenses $123.9M $133.7M $143.5M $126.9M $142.3M
Operating Income $332.3M $446.3M $544.4M $545.1M $544.2M
 
Net Interest Expenses $11.7M $13.2M $7.2M $6.9M $7M
EBT. Incl. Unusual Items $321.5M $434.1M $538.5M $539.3M $538.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $65M $102M $127.1M $106.2M $109.3M
Net Income to Company $256.5M $332.1M $411.4M $433.2M $429.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $256.5M $332.1M $411.4M $433.2M $429.3M
 
Basic EPS (Cont. Ops) $69.19 $93.25 $125.97 $132.92 $139.65
Diluted EPS (Cont. Ops) $65.11 $86.44 $118.51 $125.26 $130.50
Weighted Average Basic Share $3.7M $3.6M $3.3M $3.3M $3.1M
Weighted Average Diluted Share $3.9M $3.8M $3.5M $3.5M $3.3M
 
EBITDA $338.7M $452.1M $550M $550.4M $550.3M
EBIT $333.1M $447.4M $545.7M $546.2M $545.7M
 
Revenue (Reported) $2B $2.4B $2.8B $2.6B $2.7B
Operating Income (Reported) $332.3M $446.3M $544.4M $545.1M $544.2M
Operating Income (Adjusted) $333.1M $447.4M $545.7M $546.2M $545.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7.2B $9.1B $10.1B $9.8B $10.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.7B $6.9B $7.3B $7.2B $7.5B
Gross Profit $1.5B $2.1B $2.7B $2.6B $2.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $507.3M $548.3M $611.2M $667.7M $694.1M
Other Inc / (Exp) $3M $3.9M $4.5M $4.6M $5.1M
Operating Expenses $491M $536.3M $593.9M $539M $542.5M
Operating Income $1B $1.6B $2.1B $2B $2B
 
Net Interest Expenses $34.3M $53.1M $45.8M $27.8M $27.6M
EBT. Incl. Unusual Items $988M $1.5B $2.1B $2B $2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $135.6M $341.8M $499.9M $382.7M $392.3M
Net Income to Company $852.4M $1.2B $1.6B $1.6B $1.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $852.4M $1.2B $1.6B $1.6B $1.6B
 
Basic EPS (Cont. Ops) $231.50 $331.74 $480.15 $504.89 $520.08
Diluted EPS (Cont. Ops) $216.98 $309.03 $447.81 $475.13 $489.16
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $1B $1.6B $2.2B $2.1B $2.1B
EBIT $1B $1.6B $2.2B $2B $2.1B
 
Revenue (Reported) $7.2B $9.1B $10.1B $9.8B $10.1B
Operating Income (Reported) $1B $1.6B $2.1B $2B $2B
Operating Income (Adjusted) $1B $1.6B $2.2B $2B $2.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.2B $6.7B $7.8B $7.1B $7.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.1B $5.1B $5.7B $5.2B $5.7B
Gross Profit $1.1B $1.6B $2.2B $1.9B $2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $375.8M $414.3M $462M $504.4M $518.5M
Other Inc / (Exp) $2.2M $2.9M $3.7M $3.3M $3.9M
Operating Expenses $366M $409.6M $446.6M $397.3M $407.7M
Operating Income $718.1M $1.2B $1.7B $1.5B $1.6B
 
Net Interest Expenses $27.7M $39.9M $32.6M $20.9M $20.8M
EBT. Incl. Unusual Items $692.7M $1.2B $1.7B $1.4B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $96.4M $261.5M $407.7M $262.8M $318.4M
Net Income to Company $596.2M $902.1M $1.3B $1.2B $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $596.2M $902.1M $1.3B $1.2B $1.2B
 
Basic EPS (Cont. Ops) $161.72 $249.66 $383.68 $363.07 $391.62
Diluted EPS (Cont. Ops) $152.57 $232.10 $358.72 $341.69 $367.60
Weighted Average Basic Share $11.1M $10.9M $9.9M $9.8M $9.4M
Weighted Average Diluted Share $11.7M $11.7M $10.6M $10.4M $10M
 
EBITDA $737.2M $1.2B $1.7B $1.5B $1.6B
EBIT $720.4M $1.2B $1.7B $1.5B $1.6B
 
Revenue (Reported) $5.2B $6.7B $7.8B $7.1B $7.7B
Operating Income (Reported) $718.1M $1.2B $1.7B $1.5B $1.6B
Operating Income (Adjusted) $720.4M $1.2B $1.7B $1.5B $1.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.1B $2.8B $2.6B $2.5B $3.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $18.3M $18.3M $18.6M $20.8M $29M
Inventory $1.3B $1.7B $1.9B $1.8B $2B
Prepaid Expenses $413.9M $387.6M $497.1M $496.1M $576.6M
Other Current Assets -- -- -- -- --
Total Current Assets $3.4B $5.4B $5.4B $5.2B $6B
 
Property Plant And Equipment $83M $70.1M $72.4M $90.7M $100.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $126.8M $142M $170.2M $172.5M $296.1M
Total Assets $3.8B $5.8B $5.8B $5.7B $6.6B
 
Accounts Payable $307M $402.6M $388M $395.4M $475.2M
Accrued Expenses $346M $440.7M $435.9M $437.2M $413M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $784.9M $1.1B $1.2B $1.1B $1.2B
 
Long-Term Debt $598.3M $1.5B $1.5B $914.9M $913M
Capital Leases -- -- -- -- --
Total Liabilities $1.5B $2.7B $2.8B $2.2B $2.2B
 
Common Stock $206K $206K $206K $206K $206K
Other Common Equity Adj -- -- -- -- --
Common Equity $2.3B $3.1B $3B $3.5B $4.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.3B $3.1B $3B $3.5B $4.4B
 
Total Liabilities and Equity $3.8B $5.8B $5.8B $5.7B $6.6B
Cash and Short Terms $1.1B $2.8B $2.6B $2.5B $3.2B
Total Debt $598.3M $1.5B $1.5B $914.9M $913M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $2.6B $2.7B $1.8B $2.9B $2.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $21.5M $22.5M $28.4M $33.9M $35.6M
Inventory $1.8B $1.9B $2.2B $2B $2.3B
Prepaid Expenses $377.1M $453.3M $521.6M $530.2M $668.4M
Other Current Assets -- -- -- -- --
Total Current Assets $5.1B $5.4B $4.9B $5.9B $5.9B
 
Property Plant And Equipment $73.2M $75.3M $87.7M $103.1M $103M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $273.2M $283.7M $388.2M $346.8M $389.9M
Total Assets $5.5B $5.8B $5.4B $6.4B $6.5B
 
Accounts Payable $388.3M $379.9M $496M $440.6M $437.2M
Accrued Expenses $387.8M $416.3M $427.1M $386.3M $406.3M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $987.2M $1.2B $1.3B $1.2B $1.2B
 
Long-Term Debt $1.5B $1.5B $915.3M $913.5M $911.6M
Capital Leases -- -- -- -- --
Total Liabilities $2.6B $2.8B $2.3B $2.2B $2.2B
 
Common Stock $206K $206K $206K $206K $206K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.9B $3B $3.1B $4.2B $4.3B
 
Total Liabilities and Equity $5.5B $5.8B $5.4B $6.4B $6.5B
Cash and Short Terms $2.6B $2.7B $1.8B $2.9B $2.5B
Total Debt $1.5B $1.5B $915.3M $913.5M $911.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $878.5M $901.2M $1.2B $1.7B $1.6B
Depreciation & Amoritzation $20.8M $22M $19.5M $17.4M $16.9M
Stock-Based Compensation $78.5M $50.8M $58.2M $82.5M $99.5M
Change in Accounts Receivable $2.8M -$1.7M $2M -$27.4M -$59.7M
Change in Inventories -$94.2M -$362.4M -$238.3M $159.1M -$161.9M
Cash From Operations $866.5M $925.3M $1.2B $1.9B $1.5B
 
Capital Expenditures $22.7M $16.1M $17.9M $18.4M $24.9M
Cash Acquisitions -$702K -$435K -$1.3M -$9.7M -$1.8M
Cash From Investing -$13.3M -$3.9M -$18.2M -$27.4M -$24.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $923.9M -- -- --
Long-Term Debt Repaid -$306K -$989K -$1.4M -$601.5M -$1.7M
Repurchase of Common Stock -$698.4M -$371.1M -$1.5B -$1.5B -$1.1B
Other Financing Activities -- -$5.1M -- -- --
Cash From Financing -$424.7M $727.6M -$1.4B -$1.9B -$833M
 
Beginning Cash (CF) $732.2M $1.2B $2.8B $2.6B $2.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $428.6M $1.6B -$172.8M -$62.5M $640.9M
Ending Cash (CF) $1.2B $2.8B $2.6B $2.6B $3.2B
 
Levered Free Cash Flow $843.8M $909.2M $1.2B $1.9B $1.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $256.5M $332.1M $411.4M $433.2M $429.3M
Depreciation & Amoritzation $5.5M $4.7M $4.2M $4.2M $4.7M
Stock-Based Compensation $13.6M $15M $26.7M $26.1M $19.2M
Change in Accounts Receivable -$235K $2M -$52.7M -$21.8M -$2.5M
Change in Inventories -$160.6M $109.8M $208.3M $16.3M -$13M
Cash From Operations $208.7M $461.3M $605.7M $658.1M $358.3M
 
Capital Expenditures $4.1M $5.3M $3.2M $7.1M $8.2M
Cash Acquisitions -$397K -$202K -- -- -$741K
Cash From Investing -$4.3M -$5.4M -$3M -$6.9M -$8.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $325M -- -- -- --
Long-Term Debt Repaid -$253K -$347K -$384K -$422K -$753K
Repurchase of Common Stock -- -$398.5M -$368.5M -$484.3M -$357.5M
Other Financing Activities -$1.2M -- -- -- --
Cash From Financing $360.1M -$372.7M -$345.3M -$439.2M -$309.9M
 
Beginning Cash (CF) $2B $2.7B $1.6B $2.8B $2.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $564.5M $83.2M $257.4M $211.9M $39.7M
Ending Cash (CF) $2.6B $2.7B $1.8B $3B $2.6B
 
Levered Free Cash Flow $204.6M $455.9M $602.5M $651M $350.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $852.4M $1.2B $1.6B $1.6B $1.6B
Depreciation & Amoritzation $22.3M $19.9M $18M $16.7M $17.8M
Stock-Based Compensation $55.4M $58.1M $73.8M $97.6M $80.5M
Change in Accounts Receivable $8.2M -$964K -$64.8M $24.1M $5M
Change in Inventories -$267.3M -$100.3M -$306.9M $166.7M -$253.6M
Cash From Operations $936.4M $1.3B $1.3B $1.8B $1.2B
 
Capital Expenditures $18.3M $15.7M $17.9M $25M $30M
Cash Acquisitions -$802K -$861K -$9.6M -$1.7M -$2.2M
Cash From Investing -$18.1M -$3.8M -$26.8M -$24.1M -$26.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$855K -$1.3M -$601.5M -$1.6M -$2.2M
Repurchase of Common Stock -$549.5M -$1.3B -$1.8B -$911.6M -$1.8B
Other Financing Activities -- -- -- -- --
Cash From Financing $558M -$1.2B -$2.2B -$646.7M -$1.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5B $155.6M -$926.7M $1.1B -$401.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $918.2M $1.3B $1.3B $1.8B $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $596.2M $902.1M $1.3B $1.2B $1.2B
Depreciation & Amoritzation $16.8M $14.7M $13.2M $12.6M $13.4M
Stock-Based Compensation $35.6M $42.9M $58.4M $73.5M $54.5M
Change in Accounts Receivable -$3.1M -$2.3M -$69.1M -$17.6M $47M
Change in Inventories -$416.5M -$154.4M -$223.1M -$215.5M -$307.2M
Cash From Operations $579.3M $982.3M $1.1B $1B $737.4M
 
Capital Expenditures $12.3M $11.9M $12M $18.5M $23.6M
Cash Acquisitions -$435K -$861K -$9.2M -$1.2M -$1.6M
Cash From Investing -$12.1M -$12M -$20.6M -$17.4M -$19.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $923.9M -- -- -- --
Long-Term Debt Repaid -$665K -$1M -$601.1M -$1.2M -$1.8M
Repurchase of Common Stock -$216.6M -$1.2B -$1.4B -$795.4M -$1.5B
Other Financing Activities -$4.8M -- -- -- --
Cash From Financing $864.4M -$1B -$1.8B -$589.5M -$1.4B
 
Beginning Cash (CF) $4.3B $8.3B $6.4B $8.2B $8.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.4B -$61.7M -$815.6M $395.5M -$646.8M
Ending Cash (CF) $5.7B $8.2B $5.6B $8.6B $8B
 
Levered Free Cash Flow $567M $970.3M $1B $983.8M $713.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock